- Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Conditions: Bradycardia; Desaturation
Interventions: Drug: Provision of atropine; Drug: Placebo
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified May 2012 - Condition: Upper Respiratory Infections
Intervention: Drug: IFF flavor 316 282, Paracetamol, Pseudoephedrine
Sponsors: Novartis; Novartis; Novartis Consumer Health
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium; Drug: Olodaterol; Drug: Tiotropium; Drug: tiotropium + olodaterol; Drug: Olodaterol; Drug: Olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: Tiotropium; Drug: Tiotropium; Drug: Oldaterol; Drug: Tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium+olodaterol; Drug: tiotropium + olodaterol (high dose); Drug: placebo to tiotropium+olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Asthma; Education
Intervention: Other: Asthma Transition Program
Sponsors: University of Calgary; University of Calgary
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: AIM-102, D-cyclohexylalanine-D-glutamic-glycine tripeptide; Drug: Buffered Saline
Sponsors: AIM Therapeutics Inc.; AIM Therapeutics Inc.
Not yet recruiting - verified December 2011 - Condition: Papulopustular Rosacea (PPR)
Interventions: Drug: CD5024; Drug: Azelaic acid 15% Gel
Sponsors: Galderma; Galderma
Recruiting - verified April 2012 - Conditions: Chronic Obstructive Pulmonary Diseases; Chronic Airways Limitation; Bronchitis
Interventions: Drug: Mepolizumab; Drug: placebo
Sponsors: McMaster University; McMaster University
Recruiting - verified October 2011 - Condition: Crohn's Disease
Intervention: Drug: Entocort
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Formoterol Fumarate; Drug: placebo
Sponsors: Forest Laboratories; Forest Laboratories; Almirall, S.A.
Recruiting - verified March 2012 - Condition: Crohn's Disease
Intervention: Drug: Entocort
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Respiratory Tract Infections; Bronchiolitis Obliterans; Cryptogenic Organizing Pneumonia; Lung Diseases, Interstitial
Interventions: Drug: Prednisone; Drug: Azithromycin; Drug: Montelukast; Drug: Symbicort
Sponsors: Maisonneuve-Rosemont Hospital; Maisonneuve-Rosemont Hospital; The Canadian Blood and Marrow Transplant Group
Recruiting - verified January 2012 - Conditions: Respiratory Tract Infections; Asthma; Avitaminosis
Interventions: Drug: Vitamin D - Cholecalciferol 400 IU; Drug: Vitamin D3 - Cholecalciferol 2000 IU
Sponsors: The Hospital for Sick Children; The Hospital for Sick Children; Mount Sinai Hospital, Canada; St. Michael's Hospital, Toronto
Recruiting - verified September 2011 - Condition: Atopic Asthma
Interventions: Procedure: Bone Marrow Aspiration; Procedure: Tonsil Biopsy
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: AMG 157 Matching Placebo; Drug: AMG 157
Sponsors: Amgen; Amgen
Not yet recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Tralokinumab
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified January 2012 - Condition: Chronic Rhinosinusitis
Interventions: Device: Mucosal Atomization Device (MAD); Device: Budesonide via Nasal Syringe
Sponsors: St. Paul's Hospital, Canada; St. Paul's Hospital, Canada
Not yet recruiting - verified January 2011 - Condition: Asthma
Interventions: Behavioral: Motivational Interviewing; Behavioral: Control
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; Jewish General Hospital
Recruiting - verified October 2011 - Condition: Hereditary Angioedema
Intervention: Drug: icatibant
Sponsors: Shire Human Genetic Therapies, Inc.; Shire Human Genetic Therapies, Inc.
Recruiting - verified May 2012 - Condition: Severe Asthma
Intervention: Device: Alair System
Sponsors: Asthmatx, Inc.; Asthmatx, Inc.; Boston Scientific Corporation
Recruiting - verified March 2012 - Condition: Flexible Nasendoscopy
Interventions: Drug: 0.05% xylometazoline hydrochloride with 1% lidocaine hydrochloride; Drug: 0.05% xylometazoline hydrochloride; Drug: Isotonic normal saline
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia
Recruiting - verified June 2011 - Condition: Asthma
Interventions: Drug: salbutamol; Drug: Placebo
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified January 2012 - Condition: Allergic Contact Dermatitis
Intervention: Drug: Calcipotriol, Betamethasone, Calcipotriol & Betamethasone
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified August 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Bronchiectasis
Interventions: Drug: Aztreonam for Inhalation Solution (AZLI); Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified June 2011 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Cephalon; Cephalon
Recruiting - verified April 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Cardiovascular Disease
Interventions: Drug: fluticasone furoate/vilanterol; Drug: fluticasone furoate; Drug: vilanterol; Other: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Reslizumab; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified April 2012 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified April 2012 - Condition: Lung Diseases
Interventions: Device: Exercise DVD; Behavioral: Usual Care
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Capital Health, Canada
Recruiting - verified July 2011 - Condition: Lacerations
Intervention: Drug: LET - Lidocaine Epinephrine Tetracaine
Sponsors: Children's Hospital of Eastern Ontario; Children's Hospital of Eastern Ontario
Recruiting - verified February 2012 - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Allergy, Genes and Environment Network (AllerGen); Networks of Centres of Excellence (NCE)
Recruiting - verified November 2011 - Condition: Scalp Psoriasis
Intervention: Drug: LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified February 2012 - Condition: Acute Asthma
Interventions: Behavioral: Opinion Leader letter; Behavioral: Involvement of a care manager; Behavioral: Usual care
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Condition: Otitis Media With Effusion
Interventions: Drug: Lansoprazole; Drug: Placebo
Sponsors: McMaster University; Hamilton Health Sciences Corporation; McMaster University
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Other: Electronic Asthma Action Plan System
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto
Not yet recruiting - verified May 2011 - Conditions: Asthma; Cough Variant Asthma
Interventions: Drug: high-dose methacholine challenge test; Other: mannitol challenge test
Sponsors: Queen's University; Queen's University; The Ontario Thoracic Society of the Ontario Lung Association; Queen's University (William M Spear / Start Memorial Fund)
Recruiting - verified April 2012 - Conditions: Asthma; Rhinitis
Intervention: Drug: Mometasone furoate and desloratadine
Sponsors: Laval University; Laval University
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Behavioral: Aerobic exercise; Behavioral: Usual care
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; McGill University Health Center
Recruiting - verified October 2011 - Conditions: Deglutition Disorders; Esophageal Diseases; Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; Institute of Social and Preventive Medicine, University Bern; Dept. of Gastroenterology, Kantonsspital Olten, Olten; Luzerner Kantonsspital; Mayo Clinic Rochester, Minnesota, USA; University of Cincinnati; University of Colorado, Denver; Northwestern University of Chicago, Illinois, USA; Indiana University School of Medicine; Philadelphia University
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: tiotropium; Drug: long acting beta agonist
Sponsors: University of Alberta; University of Alberta; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified July 2011 - Condition: Atopic Dermatitis
Intervention:
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified March 2012 - Conditions: Asthma; COPD
Intervention: Drug: salbutamol
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified September 2011 - Condition: Churg-Strauss Syndrome
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012
 |
Join Clinical Trials for Asthma - Canada |
